Back to CVE records
Low 3.2HealthcarePublished Nov 28, 2023

CVE-2023-29066Incorrect User Management

Updated under an hour ago ()

Does this affect you?

It affects Becton, Dickinson and Company (BD) FACSChorus and 1 other product. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.27%, higher than 18% of scored CVEs.

The FACSChorus software does not properly assign data access privileges for operating system user accounts. A non-administrative OS account can modify information stored in the local application data folders.

CVSS
3.2 LOW (v3.1, CNA)CVSS:3.1/AV:P/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:L
Weakness (CWE)
CWE-266
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.27% (percentile 18)
Assigned by
BD
NVD analysis
Modified
Record last updated
Feb 25, 2026
First seen by InfoSec Signals
Oct 12, 2026

Affected products

Affected products
Becton, Dickinson and Company (BD) FACSChorus
becton_dickinson_and_company_bd:facschorus (from the name)
from 5.0 through 5.1
CNA record
bd facschorus
bd:facschorus
5.0; 5.1; 3.0; 3.1
NVD

References

  • vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.